OMECAP – 40 MG INJ.
OMECAP - 40 MG INJ.
Omeprazole BP 40 mg/vial
Business Unit: Human
Medicine Type: Injectable
Generic Name: Omeprazole BP 40 mg/vial
Therapeutic Class: Anti-ulcerant - Proton Pump Inhibitor
Indication: Omecap is an ideal preparation of Omeprazole which is a proton pump inhibitor. Omeprazole is indicated for the treatment of- Gastric and duodenal ulcer NSAID-associated duodenal and gastric ulcer As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer Gastro-esophageal reflux disease Long-term management of acid reflux disease Acid-related dyspepsia Severe ulcerating reflux esophagitis Prophylaxis of acid aspiration during general anesthesia Zollinger-Ellison syndrome Helicobacter pylori-induced peptic ulcer.
Dosage & Administration: IV Injection- Prophylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery. Duodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended. Zollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.
Preparation: 1 ml x1 Injection